maryland.gov

Maryland Alcohol and Drug Abuse Administration (for pda/handhelds)

skip to content | access shortcuts
  • Email Friend
  • print page

 

 

ADAA

  • General Information
  • Information Technology
  • Employment Opportunities
  • Justice Services
  • Legislation & Regulations
  • Management Services
  • OETASQuality Assurance
  • Reports/Publications
  • Research
  • Statewide Services
  • State Opioid Treatment Authority

HOT TOPICS

  • Behavioral Health Integration
  • RecoveryNet (ATR III)
  • Buprenorphine Initiative
  • Environmental Strategies
  • Gambling
  • MSPF - Maryland Strategic Prevention Framework
  • Medical Assistance
  • Prescription Drug Monitoring Program (PDMP)
  • Recovery Oriented Systems of Care (ROSC)

OTHER RESOURCES

  • Publications
  • Substance Abuse Resources
  • State and Local Councils

DIRECTIONS TO ADAA

SAVE THE DATE

 

Related External Link

  • USA.gov
  • Department of Health & Mental Hygiene
  • Office of Health Care Quality
  • SAMHSA
  • Maryland Board of Professional Counselors

MA/PAC HOTLINE

1-800-226-2142

  • HOME
  • DHMH
  • NEED HELP
  • PROVIDERS
  • TRAINING
  • CONTACT US
  • Publications

Buprenorphine Initiative | Buprenorphine Resources

ADAA met with funded providers on January 3, 2008 to present guidelines for the dissemination of funding to regions for establishing/enhancing buprenorphine treatment delivery systems. Below are links to hand-outs from the meeting.

Buprenorphine Initiative Powerpoint Presentations

  • Buprenorphine Treatment and Delivery of Care ADAA Presentation Online - March 31, 2008 (In order to view this presentation, save it to your computer.  Presentation will open in powerpoint, from there select "Slide View" - "View Show".)


ADAA Buprenorphine Initiative

  • ADAA Buprenorphine Diversion Control Plan
  • Starting Up a Jurisdictional Buprenorphine Project
  • Patient Information and Consent to Treatment with Buprenorphine (Sample)
  • Agreement for Treatment with Subutex®/Suboxone® (Sample)
  • Consent for Treatment with Buprenorphine (Sample)
  • Vermont Practice Guidelines (Sample)
  • SAMHSA's Tip 40 - Clinical Guidelines for the Use of Buprenorphine in the Treatment of Opioid Addiction
  • SAMHSA's Tip 43 - Medication Assisted Treatment for Opioid Addiction in Opioid Treatment Programs

BSAS Buprenorphine Initiative

  • Baltimore Substance Abuse Systems, Inc. - Summary of Baltimore Buprenorphine Initiative Requirements (DRAFT) - December 19, 2007
  • Buprenorphine Maintenance Treatment - Protocol for Follow-Up Appointments
  • Buprenorphine Patient Transfer Summary (To Primary Care Providers for Buprenorphine Therapy)
Office of the Governor

News Updates

  • Events | Traffic | Weather
  • Bay Bridge Traffic 1-877-BAYSPAN
  • History and Archives
  • State Announces Emergency Regulations to Ban Synthetic Drugs Known as "Bath Salts" 10.18.11

 

Online Services

  • A State Job
  • Birth, Marriage, Death Certificates
  • My refund status
  • Child support information
  • Real Property Database
  • Sex Offender Registry
  • State Employees

More Services >

Find Something

  • COMAR
  • Continuing Care Flyer
  • Primary Adult Care (PAC)
  • Treatment Coordinators
  • Prevention Coordinators
  • 8505 Evaluators
  • Help Tips and Hints
  • Frequently Asked Questions (FAQ's)

 

Additional Quick Links

  • Maryland Community Services Locator
    MDCOMMERLocator
  • "We Don't Serve Teens Campaign"Don't Serve Teens

 

Contact the Office  |   Accessibility  |   Privacy Notice  |   Terms of Use

55 Wade Avenue - Catonsville, MD 21228 - (410) 410-402-8600 or 1-877-463-3464